1 Department of Biomedical Engineering, Boston University, Boston, MA, USA.
SLAS Discov. 2017 Sep;22(8):985-994. doi: 10.1177/2472555217705953. Epub 2017 Apr 26.
The parallel microfluidic cytometer (PMC) is an imaging flow cytometer that operates on statistical analysis of low-pixel-count, one-dimensional (1D) line scans. It is highly efficient in data collection and operates on suspension cells. In this article, we present a supervised automated pipeline for the PMC that minimizes operator intervention by incorporating multivariate logistic regression for data scoring. We test the self-tuning statistical algorithms in a human primary T-cell activation assay in flow using nuclear factor of activated T cells (NFAT) translocation as a readout and readily achieve an average Z' of 0.55 and strictly standardized mean difference of 13 with standard phorbol myristate acetate/ionomycin induction. To implement the tests, we routinely load 4 µL samples and can readout 3000 to 9000 independent conditions from 15 mL of primary human blood (buffy coat fraction). We conclude that the new technology will support primary-cell protein-localization assays and "on-the-fly" data scoring at a sample throughput of more than 100,000 wells per day and that it is, in principle, consistent with a primary pharmaceutical screen.
平行微流控细胞仪 (PMC) 是一种成像流式细胞仪,它基于低像素计数的一维 (1D) 线扫描的统计分析进行操作。它在收集数据方面非常高效,适用于悬浮细胞。在本文中,我们提出了一种针对 PMC 的监督式自动化流水线,通过结合多元逻辑回归进行数据分析评分,最大限度地减少操作人员的干预。我们在流式细胞术的人原代 T 细胞激活实验中测试了自调整统计算法,使用核因子活化 T 细胞 (NFAT) 易位作为读出结果,平均 Z'达到 0.55,标准化均值差为 13,与标准佛波醇 12,13-二酯/离子霉素诱导严格相符。为了实施这些测试,我们通常加载 4 µL 样本,并且可以从 15 mL 的人外周血(白细胞层)中读出 3000 到 9000 个独立条件。我们得出结论,这项新技术将支持原代细胞蛋白定位分析,并在每天超过 100,000 个孔的样品通量下实现“实时”数据评分,并且原则上与原药筛选一致。